[Target identification of novel orally active anti-inflammatory compounds].
ayatoshi_andou@ajinomoto.com
Ayatoshi
A
Andou
Takashi
T
Yamamoto
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D018664:Interleukin-12 / Q000037:antagonists & inhibitors*; D053759:Interleukin-23 / Q000037:antagonists & inhibitors*; D008264:Macrophages / Q000187:drug effects; D051379:Mice; D058990:Molecular Targeted Therapy; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors
D000893:Anti-Inflammatory Agents; D018664:Interleukin-12; D053759:Interleukin-23; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; C492139:PIKFYVE protein, human